Adagio Medical Stock (NASDAQ:ADGM)

Revenue Financials Chart

Previous Close

$1.24

52W Range

$0.63 - $9.34

50D Avg

$1.05

200D Avg

$2.32

Market Cap

$18.46M

Avg Vol (3M)

$2.10M

Beta

0.19

Div Yield

-

ADGM Company Profile

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

80

IPO Date

Jul 23, 2024

Website

ADGM Performance

ADGM Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$269.00K	$300.00K	$189.00K
Operating Income	$-62.48M	$-27.94M	$-1.01M
Net Income	$-53.76M	$-38.15M	$1.07M
EBITDA	$-62.48M	$-27.41M	$-23.42M
Basic EPS	$-3.38	$-0.16	$0.06
Diluted EPS	$-3.70	$-0.16	$0.06

Fiscal year ends in Dec 24 | Currency in USD